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Abstract
Introduction: In this study, a single-blind and randomized controlled trial (RCT) for assessing the 
effectiveness of high-power (up to 12 W) laser therapy (HPLT) on patients with patellofemoral pain 
syndrome (PFPS) was carried out.
Methods: Forty-four patients were randomly assigned to two treatment groups by generating 
random numbers with MATLAB 2014b software, where odd and even numbers were attributed 
to sham laser group (group A) and actual laser group (group B), respectively. Group B patients 
underwent HPLT with total dose of 300 J/session for 5 consecutive sessions separated by a 2-day 
interval. On the other hand, sham laser was applied to group A patients. Both groups had the 
same exercise therapy programs during the study period (3 months). The exercise therapy program 
included isometric knee exercise for 3 sets per day and 10 times in each set, with duration of 10 
seconds per time and straight leg raise for 15 seconds 10 times a day. The group codes of patients 
were not revealed to subjects and data analyzer until completion of the study. Kujala, the Western 
Ontario and McMaster Universities Osteoarthritis Index (WOMAC) and visual analog scale (VAS) 
questionnaires were chosen as outcome measures. These questionnaires were completed at three 
points during the study; at the beginning of the study to obtain the pre-therapy conditions and one 
month and three months after the start of the study to evaluate post-therapy conditions.
Results: Two main analyses were conducted: within-group and between-group analyses. Within-
group analyses indicated significant improvements in respect to all measurements where pre-
therapy and post-therapy comparisons were conducted in both groups (P < 0.05). On the other 
hand, between-group comparisons did not reveal any statistically significant functional difference 
between group A and group B regarding the evaluative criteria (P > 0.05) except for pain VAS (P 
< 0.05). 
Conclusion: This study indicated that short-term HPLT accompanied by appropriate exercise 
regimen significantly decreased pain in patients with PFPS. But it was not recommended as an 
efficient modality in functional improvement. Also, it was observed that, in the short-term period 
of study, HPLT was a safe modality.
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Introduction
Patellofemoral pain syndrome is one of the most common 
musculoskeletal disorders in athletes or active young 
adults.1-4 The pain existing in anterior knee or posterior 
patella without other knee pathologies is called PFPS. 
The prevalence of PFPS is about 1.5% to 7% in patients 
referring to medical centers with more occurrence in 
females and athletes.5,6 Although the main cause of this 
syndrome is unknown, some researchers believe that the 
pain can be attributed to some biomechanical, soft tissue 
or muscular abnormalities.7,8 This syndrome causes pain 
and functional impairment in the corresponding patients 
and may result in chronic pain and/or weaknesses in 
quadriceps muscles, if not treated well. One way to 
approach this syndrome is related to physical activities. 
In the literature, a number of randomized controlled 
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trials (RCTs) and systematic reviews studied the efficacy 
of different treatments and interventions in PFPS that 
highlighted the importance of exercise therapy.8-10 
Low-level laser therapy has been already applied to 
musculoskeletal pains such as carpal tunnel syndrome11,12 
and knee osteoarthritis (OA).13 Recently, many studies 
have explored the efficacy of high power laser therapy 
in various musculoskeletal disorders such as low back 
pain,14 knee OA,15,16 lateral epicondylitis,17 subacromial 
impingement18 etc. Despite the growing use of high-
power lasers in alleviating musculoskeletal pains and its 
confirmed physiologic effects,19,20 studies investigating 
the effect of high-power laser in pain management and 
function of patients with PFPS are very limited. Thus, 
the focus of this study is on analyzing the efficacy of high 
power laser in treatment of patients with PFPS. To do so, 
a single-blinded randomized clinical trial was designed 
in order to investigate the efficacy of high power laser in 




Patients referred to the outpatient physical medicine 
and rehabilitation (PM&R) clinic of Shahid Modarres 
and Shohadaye Tajrish hospitals with anterior knee joint 
or posterior patella pain were evaluated using the most 
sensitive and specific tests (Shrug, Grind and Perkins test) 
to see if they were diagnosed with PFPS.21 Those with 
at least two positive tests were considered as potential 
subjects. It is worth noting that these tests were carried 
out by two PM&R specialists. Of the total 78 patients 
diagnosed with PFPS, 34 were disqualified with regard 
to the inclusion and exclusion criteria. For the rest of 
patients, the research procedure, its main objectives and 
a description of high-power laser was elaborated and after 
obtaining written informed consents, they were included 
in the trial.
The inclusion criteria of this study were as follows. 
Patients aged 15 to 40 years referring to the outpatient 
PM&R clinic of Shahid Modarres and Shohadaye 
Tajrish hospitals in year 2017 with positive diagnostic 
patellofemoral syndrome maneuvers including Shrug 
test, Grind test and Perkins test (at least 2 of them being 
positive) who had the symptoms for at least 3 months 
were included in this study. Having normal knee x-ray in 
3 dimensions (A-P, lateral and patella view) was also an 
inclusion criterion.
On the other hand, patients aged younger than 15 years or 
older than 40, history of knee surgery, a body mass index 
of greater than 30 kg/m2, any systemic diseases such as 
diabetes mellitus, immunodeficiency or collagen vascular 
disorders were excluded. Furthermore, having a history of 
malignancy, recent knee trauma, any infection, any knee 
deformities or signs of knee OA in knee x-ray, pregnancy 
or breastfeeding were considered as exclusion criteria.
Equipment
The active laser used in this study was a BTL-6000 
high intensity laser with a wavelength of 1064 nm and 
a maximum power of 12 W. For the active laser group, 
actual laser was utilized by a PM&R specialist according 
to the protocol recommended by the device manufacturer. 
Based on the suggested protocol, Pain Relief program 
(with 10 W and 120 J/cm2) for 120 seconds were 
exploited per therapy session. Pulsed laser in circulatory 
movements on patellar margins with duty factor of 25% 
was used while patients were supine with knee positioned 
in full extension (resting position of patellofemoral joint). 
The spot size was 0.8 cm2 and applicator distance from 
skin was 2 cm. The same protocol by the same device with 
the same duration and positioning was also applied to the 
sham laser group where the device was in inactive mode 
and no laser beam was emitted. It should be pointed out 
that all 5 sessions were identical regarding the protocol, 
the positioning of laser and the therapy duration.
Study Design, Randomization and Blinding
Patients’ personal and clinical information comprising 
age, gender, weight, body mass index (BMI), duration 
of symptoms, degree of joint stiffness and pain and their 
functional performance were gathered by the physician 
prior to the study using visual analog scale (VAS), Western 
Ontario and McMaster Universities Osteoarthritis Index 
(WOMAC) and Kujala questionnaires. VAS is a qualitative 
pain measurement tool that assigns integer numbers 
between zero and 10 to different pain levels, where zero 
means no pain and 10 means excruciating pain.22 Kujala 
is a questionnaire for quantifying the functionality of 
patients, where zero indicates complete disability and 
100 denotes full functionality. Kujala questionnaire was 
translated into Persian and its validity and reliability 
for PFPS patients were confirmed.23 WOMAC is a 
questionnaire containing 24 questions for evaluating 
function, stiffness and pain in lower limb and knee. It was 
translated into Persian and its reliability and validity was 
shown in patients with knee OA.24
The initial conditions of patients included in the study 
were examined by their baseline characteristics shown in 
Table 1. The data indicated that no significant difference 
was observed between the 2 groups regarding their pre-
therapy measurement values.
Afterwards, 44 patients were randomly assigned to 2 
study groups through generating random numbers with 
MATLAB 2014b software by PM&R specialist, that odd 
numbers were attributed to sham laser group (group A) 
and even numbers were assigned to actual laser group 
(group B). Neither the subjects nor the researchers know 
the group code of patients until the completion of data 
analyses. The sample size for our study was computed 
according to the work of van Linschoten et al25 that 
performed analogous comparisons.
Group B patients underwent high-power laser therapy 
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(HPLT) for 5 consecutive sessions separated by a 2-day 
interval. Each patient was exposed to 120 seconds of 
10-W laser with 120 J/cm2 per therapy session. On the 
other hand, sham laser was utilized for group A patients 
who were not aware of the inactiveness of the laser device.
In addition to the laser therapy program, both groups 
had the same exercise therapy programs during the study 
period (3 months). In both groups, we used the same 
exercise program. Our quadriceps muscle strengthening 
program included isometric knee exercise for 3 sets 
per day and 10 times in each set, with duration of 10 
seconds per time and straight leg raising for 15 seconds 
10 times a day, this exercise regime was to be performed 
during the 3-month study period. Patients were regularly 
contacted by the PM&R specialist in order to ensure their 
compliance with the exercise therapy program and check 
for potential complications. 
Two major follow-up milestones were defined at which 
patients were brought back to their corresponding clinics 
to reassess their pain and functional performances by the 
same VAS, Kujala and WOMAC questionnaires and the 
same physician; 1 month and 3 months after the start of 
the therapy program. The obtained data at each milestone 
were recorded in a spreadsheet software program for later 
statistical analyses. 
Statistics
As mentioned previously, 3 different categories of data 
for each group were obtained during the study; Pre-
intervention data, first month data and third month data. 
Thus, 2 types of statistical analyses become necessary; 
within-group and between-group analyses. Within-
group analyses check the efficacy of each laser therapy 
program by comparing the pre-therapy and post-therapy 
data within each group. To perform within-group 
analyses, paired sample t-tests were implemented using 
the Statistical Package for the Social Sciences (SPSS) 
version 22. 
Between-group analyses, however, compare the efficacy 
of group A with group B with regard to their related 
improvements. To do so, three improvement values were 
calculated for each group by comparing pre-therapy and 
post-therapy conditions in each group. Subsequently, the 
obtained improvements values of group A were compared 
to their counterpart values of group B by independent-
samples t tests using the same SPSS software. In fact, the 
outcomes of between-group analyses determine whether 
a significant difference in the efficacy of the different 
therapy regimes exists.
The results were expressed as mean ± standard deviation 
(SD) and a 0.05 significance level was considered.
Noteworthy, the input data of patients were gathered 
using Kujala,26 WOMAC27 and VAS questionnaires. 
Since the acquired data were of ordinal type, the choice 
between parametric and nonparametric statistical tests 
was controversial28 and there is no consensus among the 
researchers29 in this regard. For example, for VAS data, 
Scott and Huskisson30 recommended using nonparametric 
methods, whereas Philip31 preferred parametric statistics. 
Comprehensive analyses conducted lately on Likert item 
data by Frost32 suggests that the choice is tie between the 
two alternatives regarding their protection against false 
positives and false negatives. Taking this inference into 
account and the fact that nonparametric tests have strict 
assumptions that cannot be disregarded, parametric tests 
were selected for this study.
Results
Participant flow diagram is illustrated in Figure 1.
As mentioned before, 44 patients were randomly 
allocated to two groups. Of these 44 patients, 4 refused 
to participate in the research; 2 because of not answering 
phone calls and 2 because of incompatibility of clinic 
schedules with their intervals. The mean BMI was almost 
the same between groups with 23.26 ± 2.84 for group A 
and 23.52 ± 3.99 for group B (P > 0.05).
The mean age of group A was 31.43 ± 6.72 and the mean 
age of group B was 35.29 ± 3.27. 
Table 1 shows a summary of initial conditions for each 
group while the pre-therapy comparisons are also 
provided. Using independent sample t tests, it can be 
seen that the starting conditions for all subjects between 
groups A and B are nearly the same.
As can be seen in Table 2, both sham and actual laser 
groups demonstrate significant improvements in all 
output measurements when pre-therapy values are 
compared to the post-therapy values (P < 0.05). However, 
there was no statistically significant difference between 
mean values of month 1 and month 3 in either treatment 
group implying that the attained improvements were 
maintained during the three-month period after active or 
sham laser therapy. 
From VAS measures viewpoint, improvements in active 
laser group (group B) during trial period were statistically 




Group A Group B
Age (y) 31.43±6.72 35.29±3.27 0.07
Gender
Male 6 6 -
Female 14 14 -
BMI 23.26±2.84 23.52±3.99 0.84
Pre-therapy comparisons
VAS 5.43±1.60 6.50±1.34 0.07
Pain WOMAC 8.00±3.64 8.86±4.02 0.56
Function WOMAC 20.57±11.34 21.93±9.31 0.73
Stiffness WOMAC 2.43±2.17 2.57±1.45 0.84
Kujala 82.21±7.10 75.43±10.23 0.053
WOMAC scores 31.00±15.70 33.36±11.78 0.66
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more significant than those of sham laser group (P < 0.05; 
Figure 2). 
Although improvements in the other measurements 
(Pain WOMAC, Function WOMAC, Stiffness WOMAC, 
Kujala and WOMAC scores) in active laser group were 
more than those of sham laser group, the differences 
were not proved to be statistically significant (P > 0.05) 
(Table 3).
Figure 3 provides visual comparisons of between-group 
and within-group improvements during the therapy 
program.
Post-therapy clinical outcomes for both actual and sham 
laser groups are shown in Table 4. It is worth mentioning 
that no complications were reported during the study 
period in either group.
Discussion
The purpose of this study was to evaluate the efficacy 
of high-power laser in decreasing pain and improving 
functions of patients with PFPS. The study showed that 
 
 
CONSORT 2010 Flow Diagram 
Assessed for eligibility (n=78) 
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 Received allocated intervention (n=22) 
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Figure 1. Participant Flow Diagram.
Figure 2. VAS Changes During the Therapy Program.
Table 2. Within-Group Comparisons Made by Paired-Samples T Test (P Value)
Group A Group B
0 vs 1 0 vs 3 1 vs 3 0 vs 1 0 vs 3 1 vs 3
VAS 0.002 0.011 0.385 0.000 0.001 0.293
Pain WOMAC 0.005 0.005 0.567 0.001 0.004 0.373
Function WOMAC 0.005 0.006 0.231 0.002 0.002 0.322
Stiffness WOMAC 0.015 0.043 0.189 0.005 0.002 0.212
Kujala 0.007 0.015 0.687 0.043 0.033 0.592





Figure 2 VAS changes during the therapy program 
Although improvements in the other measurements (Pain WOMAC, Function WOMAC, 
Stiffness WOMAC, Kujala and WOMAC scores) in active laser group were more than those of 
sham laser group, the difference  were not proved to be statistically significant (P > 0.05) (Table 
3).  
 
Table 3 Between-group Comparisons of the achieved improvements made by independent-




to month 1 
improvements from 
pre-therapy conditions 
to month 3 
improvements from 
month 1 to month 3 after 
the therapy initiation 
VAS 0.03 0.03 0.54 
Pain 
WOMAC 0.29 0.31 1 
Function 
WOMAC 0.72 0.59 0.61 
Stiffness 
WOMAC 0.90 0.26 0.09 
Kujala 0.87 0.98 0.82 
WOMAC 
scores 0.55 0.42 0.52 
 
Figures 3 to 7 provide visual comparisons of between-group and within-group improvements 























the methods, the exercise alone (sham laser group) and 
exercise combined with high-power laser (active laser 
group) had effectiveness at follow-up moments. Actual 
laser outperformed sham laser with respect to pain relief 
while no significant difference in terms of functional 
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improvement was observed.
Recently, many studies have evaluated the efficacy of HPLT 
in various musculoskeletal disorders such as low back 
pain,14 knee OA,15,16 lateral epicondylitis,17 subacromial 
impingement18 etc. Despite the mentioned studies about 
high-power laser in other musculoskeletal studies, the 
findings of this work regarding high-power laser did not 
reveal any significant superiority over sham laser, except 
for pain relief with VAS index that may be attributed to 
multifactorial nature of PFPS, difficult approachability to 
this joint or due to differences in protocols and/or doses.
To the best knowledge of authors, it was the first study in 
the literature that considered high-power laser for PFPS. 
However, the use of low-power laser for this syndrome 
was observed in some studies. Rogvi-Hansen et al,33 for 
instance, used low-power laser combined with exercise 
regime for PFPS. They found the same findings in both 
control and intervention groups as ours except for pain 
relief measured by VAS index. The pain relief achieved 
by using laser is due to laser’s biological effects on cellular 
Table 3. Between-Group Comparisons of the Achieved Improvements Made by Independent-Samples T Test (Between Group A and B) (P Value)
Improvements From Pre-therapy 
Condition to Month 1
Improvements From Pre-therapy 
Condition to Month 3
Improvements From Month 1 to Month 3 
After the Therapy Initiation
VAS 0.03 0.03 0.54
Pain WOMAC 0.29 0.31 1
Function WOMAC 0.72 0.59 0.61
Stiffness WOMAC 0.90 0.26 0.09
Kujala 0.87 0.98 0.82












































































































Figure 3. (A) Pain WOMAC, (B) Function WOMAC), (C) Stiffness WOMAC, (D) Function (Kujala), and (E) WOMAC Total Scores Changes for Each 
Group During the Therapy Program. 
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and tissue function, releasing endogen opium, thermal 
and anti-inflammatory effects which can propagate better 
in high-power lasers compared to low-power ones. 
Since PFPS has a multifactorial nature, various factors 
including quadriceps weakness, tightness of hamstring, 
iliopsoas and gastrosoleus muscles, etc are investigated 
as its potential risk factors.34 Accordingly, a diversity of 
physical activities is proposed for treatment of PFPS.35-40 
According to the obtained results, both groups showed 
significant improvements compared to the pre-therapy 
conditions. It was due to the identical exercise therapy 
that was employed by both groups. Thus, it can be 
concluded that it was an efficient regime for patients with 
PFPS, which is in accordance with the findings of similar 
investigations in the literature. Moreover, the efficacy of 
the exercise regime was improved when high-power laser 
was also included.
A limitation of this study can be attributed to the small 
number of subjects. Of the 44 potential subjects, 4 patients 
were excluded from the study because of their personal 
considerations, unrelated to the laser complication or 
so on. This limitation negatively affected the power of 
statistical tests conducted in the article. Another drawback 
can be attributed to the lack of articles in the literature 
considering the efficacy of HPLT in treating PFPS. Thus, 
we had difficulty in finding standard doses or durations 
for carrying out the HPLT. Further studies in the future 
are necessary to investigate the efficacy of HPLT with 
various doses and durations on an increased population 
of patients. Moreover, the physician was not blinded to 
the groups that might result in biased outcomes. 
This study indicated that short-term HPLT accompanied 
by appropriate exercise regimen can significantly decrease 
pain in patients with PFPS, but it cannot assume as an 
efficient modality in functional improvement.
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